Healthcare Professionals
-
Webinars
eThalED COURSE: Current Care & New Advances in Iron Chelation by Dr. Farrukh Shah
TIF´s last webinar for the eThalED series for Medical Specialists on October 16, 2020, featured Dr Farrukh Shah, Consultant Haematologist, Whittington Hospital, London, UK, who reviewed all the current practices…
Read More » -
Clinical News
Fulcrum Therapeutics to Initiate Phase 1 Trial with FTX-6058 for Sickle Cell Disease
Fulcrum Therapeutics, Inc. a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, announced that FTX-6058, its investigational treatment for sickle cell disease (SCD) and…
Read More » -
News
Gene-editing Therapy CTX-001 Granted Priority Medicines Designation for Severe SCD in EU
CTX001, an investigational gene-editing cell therapy, has been granted priority medicines (PRIME) designation by the European Medicines Agency (EMA) for the treatment of severe sickle cell disease (SCD). The announcement was made by CRISPR Therapeutics and Vertex Pharmaceuticals, which are jointly…
Read More » -
News
Coming Up: A TIF Live Webinar on ”Heart Disease in Thalassaemia”
Tune in with TIF on Tuesday, 15 September 2020, 15:00 EEST, for one of the last webinars from the TIF eThalED series for Healthcare Professionals! The topic to be brought…
Read More » -
Webinars
eThalED COURSE: Iron Monitoring in Thalassaemia by Dr Paul Telfer
TIF´s 5th consecutive webinar for Medical Specialists and Healthcare Professionals was conducted on 7 September 2020 and revolved around the topic of ”Iron Monitoring in Thalassaemia”. Dr Paul Telfer, Consultant…
Read More » -
Education
eThalED COURSE: Blood Transfusion in Thalassaemia by Dr. Farrukh Shah
TIF´s 4th Webinar for Medical Specialists and Healthcare Professionals, organised as part of our eThalED Course, was successfully held on Monday, 31 August 2020. Prof. Constantina Politis, Associate Professor of…
Read More » -
News
IMPORTANT ANNOUNCEMENT: TIF’s Renzo Galanello Fellowship Programme 2020 To Be Rescheduled and Compressed
Due to some difficulties and restrictions encountered as a result of the COVID-19 pandemic, the Renzo Galanello Fellowship Programme 2020 will not be offered in its full length and as initially…
Read More » -
News
Pfizer Has Reached Over 50% Enrollment for Coronavirus Vaccine Candidate Phase 3 Trial
One of the leading COVID-19 vaccine candidates currently in development is getting closer to a potential finish line. Pfizer said on Wednesday that the recruitment for the crucial U.S. phase 3 clinical…
Read More » -
News
Malaysian Health Minister: The Country Needs More Geneticists to Detect Thalassaemia Early
Malaysia needs more geneticists in order to identify thalassaemia patients at an early stage, stated Health Minister Datuk Seri Dr Adham Baba, after launching the 2019 Malaysia Thalassaemia Registry (MTR)…
Read More » -
TIF News
The eThalED Course Webinar Series Return With a New Session on Iron Monitoring in Thalassaemia
TIF´s upcoming webinar on ”Iron Monitoring in Thalassaemia”, specially designed and launched for medical specialists and healthcare professionals with a particular interest in the field of haemoglobin disorders and thalassaemia,…
Read More »